alpha1-antitrypsin phenotypeSummaryThe alpha1-antitrypsin (AAT) phenotype was determined by isoelectric focusing in 215 male homosexuals and compared with those in 208 male heterosexuals. The incidence of abnormal phenotypes was 16.3% in the homosexual group which was significantly different (p<0.03) ...
Alpha-1-antitrypsin (AAT) deficiency is one of many factors that may be involved in abnormalities such as liver and lung disease, inflammatory joint diseases, and inflammatory eye diseases. In this study, the role of AAT in uveitis is analyzed. Design and methods: AAT phenotyping and serum-...
Also Known As: Serum AAT Test, AAT Phenotyping, AAT Genotyping, AAT Deficiency Test, AAT DNA Sequencing Test, AAT Isoelectric Focusing Test, A1AT Test, AATD Test, Alpha-1 Protease Inhibitor Deficiency Test Test Quick Guide Alpha-1 antitrypsin (AAT) testing is performed to detect a deficiency ...
Alpha-1-antitrypsin deficiency (AATD) is a rare genetic disorder associated with the development of liver and lung disease. AAT is a 52-kD glycoprotein, produced mainly by hepatocytes and secreted into the blood. Agglomeration of the AAT-protein in hepatocytes can result in liver disease. Exposur...
阿尔法1-抗胰蛋白酶(AAT)英文名字 Alpha 1-Antitrypsin (AAT)供应商 Anogen产品货号 MO-M40096A-0.5 mg产品报价 ￥已停产产品说明书 点击查看购买方式 银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868。产品新闻背景资料 待更新...
Alpha 1-抗胰蛋白酶(Alpha-1 Antitrypsin,简称AAT)是一种由肝脏合成的血浆蛋白,它在人体中扮演着重要的保护角色,主要功能是抑制多种胰蛋白酶和其他蛋白水解酶的活性,从而保护肺部组织不受这些酶的破坏。 Alpha 1-抗胰蛋白酶在临床上的应用非常广泛,它不仅用于治疗与AAT缺乏相关的肺部疾病,如非典型肺炎、囊性纤维...
Alpha-1-antitrypsin deficiency (AAT deficiency) is one of the most common serious hereditary disorders in the world because it affects all major racial sub... FJ de Serres,I Blanco,E Fernándezbustillo - 《Clinical Genetics》 被引量: 74发表: 2010年 Alpha1-antitrypsin deficiency with severe pan...
RNAi agents for inhibiting the expression of the alpha-1 antitrypsin (AAT) gene, compositions including AAT RNAi agents, and methods of use are described. Also disclosed are pharmaceutical compositions including one or more AAT RNAi agents together with one or more excipients capable of delivering ...
The finding is recorded of typical a1-antitrypsin globules, confirmed by immunofluorescence and immunoperoxidase methods, in the hepatocytes of a patient shown to have a normal serum antitrypsin level and normal phenotype (TiM) for a1-antitrypsin. The identification of such globules can no longer be...
Alpha1-antitrypsin (AAT) deficiency was first described in 1963 together with its associations with severe early-onset basal panacinar emphysema. The genetic defects leading to deficiency have been elucidated and the pathophysiologic processes, clinical variation in phenotype, and the role of genetic mo...